PNC-27, a Chimeric P53-Penetratin Peptide Binds to HDM-2 in a P53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis
Overview
Authors
Affiliations
PNC-27, a 32-residue peptide that contains an HDM-2 binding domain and a cell-penetrating peptide (CPP) leader sequence kills cancer, but not normal, cells by binding to HDM-2 associated with the plasma membrane and induces the formation of pores causing tumor cell lysis and necrosis. Conformational energy calculations on the structure of PNC-27 bound to HDM-2 suggest that 1:1 complexes form between PNC-27 and HDM-2 with the leader sequence pointing away from the complex. Immuno-scanning electron microscopy was carried out with cancer cells treated with PNC-27 and decorated with an anti-PNC-27 antibody coupled to 6 nm gold particles and an anti-HDM-2 antibody linked to 15 nm gold particles. We found multiple 6 nm- and 15 nm-labeled gold particles in approximately 1:1 ratios in layered ring-shaped structures in the pores near the cell surface suggesting that these complexes are important to the pore structure. No pores formed in the control, PNC-27-treated untransformed fibroblasts. Based on the theoretical and immuno-EM studies, we propose that the pores are lined by PNC-27 bound to HDM-2 at the membrane surface with the PNC-27 leader sequence lining the pores or by PNC-27 bound to HDM-2.
Ben Abid S, Ketata E, Yacoubi I, Djemal L, Abdelmoula-Souissi S, Koubaa A PLoS One. 2024; 19(10):e0297338.
PMID: 39361673 PMC: 11449285. DOI: 10.1371/journal.pone.0297338.
Pincus M, Silberstein M, Zohar N, Sarafraz-Yazdi E, Bowne W Biomedicines. 2024; 12(6).
PMID: 38927351 PMC: 11201261. DOI: 10.3390/biomedicines12061144.
Miller A, Diaz D, Lin B, Krzesaj P, Ustoyev S, Shim A Biomedicines. 2023; 11(9).
PMID: 37760956 PMC: 10526402. DOI: 10.3390/biomedicines11092515.
Recent advances and applications of peptide-agent conjugates for targeting tumor cells.
Alamdari-Palangi V, Rahimi Jaberi K, Shahverdi M, Naeimzadeh Y, Tajbakhsh A, Khajeh S J Cancer Res Clin Oncol. 2023; 149(16):15249-15273.
PMID: 37581648 DOI: 10.1007/s00432-023-05144-9.
Peptides That Block RAS-p21 Protein-Induced Cell Transformation.
Pincus M, Lin B, Patel P, Gabutan E, Zohar N, Bowne W Biomedicines. 2023; 11(2).
PMID: 36831007 PMC: 9953342. DOI: 10.3390/biomedicines11020471.